Contact
QR code for the current URL

Press release Box-ID: 50310

Scienion AG Otto-Hahn-Straße 15 44227 Dortmund, Germany https://www.scienion.com
Contact Dr. Holger Eickhoff +49 30 63921700
Company logo of Scienion AG
Scienion AG

Cell Dispensing Using the sciFLEXARRAYER for Miniaturized Cell-based Assays

(PresseBox) (Berlin,, )
SCIENION’s sciFLEXARRAYER, an ultra low level liquid handling system, allows the aspiration and dispensing of single cells or low amount of cells for a variety of cell-based assays in the field of functional genomics and drug development. SCIENION’s technology for high content screening provides a unique solution to perform multiple cell-based assays in nanoliter drops, thereby increasing assay speed and reducing costs significantly.

Holger Eickhoff, CEO of Scienion AG, states: “Solutions for the miniaturization and automation of cell-based assays are in growing demand within pharmaceutical and biotech companies. With our ultra low level liquid handling system sciFLEXARRAYER we enable scientists to handle single cells or low numbers of cells.”

Using the sciFLEXARRAYER, the Laboratoire Biopuces in Grenoble, France, developed a “DropChip” cell array on a glass slide for DNA and siRNA transfection combined with drug screening (Schaack et al., NanoBiotechnology, Volume 1, 2005, 183-189). Dr. Béatrice Schaack from Laboratoire Biopuces at the CEA (French Atomic Energy Commission) states: “Using the sciFLEXARRAYER, less than 100 cells per assay can be tested, a nano-amount of drugs can be tested and single-cell phenotypes can be analyzed after contact with nucleic acids or chemicals.”

Scienion’s recent presentation of the sciFLEXARRAYER at the “LabAutomation 2006”, the world’s leading conference and exhibition on emerging laboratory technologies in Palm Springs, California, generated great interest among the participants followed up by explicit inquiries of potential customers. Upcoming events with the opportunity to find out more about the sciFLEXARRAYER and its various applications are “Screening Europe” in Prague, Czech Republic, February 20-22, and “Analytica” in Munich, Germany, April 24-28, 2006.

About Laboratoire Biopuces at the CEA (French Atomic Energy Commission)

Dr. Béatrice Schaack is coordinating a project funded by the European Community for the evaluation of cell-based assays in drops for toxicological studies. The aim of the “TOXDROP” two years project is to develop a Cell-on-Chip technology allowing the monitoring of various phenotypes illustrating cytotoxicity which can be characterized in highly parallel cell-based reactions on a glass slide. The surface of this biochip achieves the necessary precision in the formation of the cellular nano-drops and enables the high content analysis of cell cultures based on high fluorescent microscopy detection as well as mass spectrometry phenotypic signatures.

Scienion AG

Die Scienion AG ist ein Biotechnologie-Unternehmen, das Komplettlösungen im Bereich hochparalleler Bioanalytik für Kunden aus der Pharma- und Biotechbranche sowie akademischen Forschungseinrichtungen anbietet. Gegründet in Berlin im Dezember 2000 als Spin-Off aus dem Max-Planck-Institut für Molekulare Genetik, ist das Unternehmen heute an zwei Standorten tätig: am BioMedizinZentrum Dortmund und in Berlin-Adlershof. Scienion fokussierte von Anfang an als ein Anbieter für BioChip-Plattformtechnologien. Mit der erfolgreichen Markteinführung des piezoelektrischen Dispensiersystems sciFLEXARRAYER im Jahr 2003 hat sich der Unternehmensschwerpunkt auf den Hardware-Bereich verlagert. Mit dem sciFLEXARRAYER können kleinste Flüssigkeitsmengen aus verschiedenen Reservoirs aufgenommen und berührungslos in Volumina im Pikoliterbereich auf eine Vielzahl von Trägersystemen gespottet werden. Scienion hat sich mittlerweile als Komplettsystem Solution Provider von hochqualitativen Systemen für das präzise Handling kleinster Flüssigkeitsmengen etabliert, die bei einer Vielzahl von Applikationen in der Diagnostik, Proteomik und bei Hochdurchsatz-Screeningverfahren Anwendung finden.

The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2022, All rights reserved

The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.